51. Postdischarge adverse drug reactions in primary care originating from hospital care in France: a nationwide prospective study.
- Author
-
Letrilliart, L., Hanslik, T., Biour, M., Fagot, J-P., Guiguet, M., and Flahault, A.
- Subjects
- *
DRUG side effects , *CONVALESCENCE , *PRIMARY health care , *THERAPEUTICS - Abstract
Objective: To describe and estimate the incidence and preventability of postdischarge adverse drug reactions (ADRs) detected in primary care in France.Design: Prospective study of patients referred to hospital by participating general practitioners (GPs). These GPs reported all cases of an adverse reaction to a drug instituted in hospital among patients who consulted them within 30 days of discharge.Setting: 305 general practices from all French regions.Patients: 7540 patients referred by GPs to private or public hospitals.Main Outcome Measures: The incidence for postdischarge ADRs in primary care, and their preventability.Results: 30 cases of postdischarge ADR were detected in 29 re-consulting patients, yielding a minimal incidence for France of 0.4 per 100 admissions (95% confidence interval 0.3 to 0.6). The ADRs were assessed as serious in 60% of cases. The main drug classes implicated were cardiovascular drugs (8 ADRs), oral anticoagulants (6), psychoactive drugs (4), antidiabetics (3), and opioid analgesics (3). Patients experiencing a postdischarge ADR were older than patients not experiencing one (median age: 77 vs 68 years; p = 0.004). Detected ADRs were considered preventable in 59% of cases.Conclusions: Physicians and patients should be aware of the possible occurrence of postdischarge ADRs. Patient information in hospital, close postdischarge follow-up of patients at risk, and appropriate transmission of information between hospital physicians and GPs can help to prevent them. [ABSTRACT FROM AUTHOR]- Published
- 2001
- Full Text
- View/download PDF